EGFR inhibitors

The present disclosure provides a compound represented by structural formula (A) or (I):; or, or a pharmaceutically acceptable salt thereof useful for treating a cancer.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PEROLA, EMANUELE, CAMPBELL, JOHN EMMERSON, BARVIAN, KEVIN K, RIBEIRO DA SILVA, VINICIUS BARROS, ENO, MEREDITH SUZANNE, PERRON, QUENTIN, DINEEN, THOMAS A, AHMAD, OMAR, FERNANDO, DILINIE PRASADHINI
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure provides a compound represented by structural formula (A) or (I):; or, or a pharmaceutically acceptable salt thereof useful for treating a cancer.